Genetics Hall of Fame
Guillermina Lozano, Ph.D.
Raycroft L, Wu HY, Lozano G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. (1990) Science 249 (4972) 1049-51
Richard R. Behringer, Ph.D.
Shawlot W, Behringer RR. (1995) Requirement for Lim1 in head-organizer function. Nature 374(6521):425-430
Benoit DeCrombrugghe, M.D.
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29
Dr. Nicholas Navin among first recipients of the prestigious Sabin Fellows program
Nicholas Navin, Ph.D.
Beginning this year, the Andrew Sabin Family Fellowship Program funded up to eight two-year research fellowships. The program encourages creative, independent thinking and high-risk, high-impact research. Fellowships will be giving deserving early-career researchers at MD Anderson the means to strive toward their collective goal to end cancer. Dr. Navin aims to use single cell sequencing technologies to investigate tumor evolution in breast cancer patients and understand how they evolve resistance to chemotherapy. These studies are expected to lead to new diagnostic modalities and therapeutic targets to improve treatment and outcomes for breast cancer patients.
Dr. Michael Galko named Faculty Educator of the Month: January 2016
Michael Galko, Ph.D.
Director of the Genes and Development PhD Program
The Faculty Educator of the Month Recognition features outstanding MD Anderson faculty educators who demonstrate excellence and innovative practice in education.
Dr. Nicholas Navin wins notable AAAS Martin & Rose Wachtel Cancer Research Award
Nicholas Navin, Ph.D.
The American Association for the Advancement of Science (AAAS) Wachtel Award is an annual award that honors early career investigators performing outstanding work in cancer research. Winners receive a cash prize, deliver a public lecture on their research and have their award entry essay published in the journal Science Translational Medicine. Dr. Navin was selected for his research on single-cell DNA analysis. He will present his work at the National Institutes of Health on July 31, 2015.